Abstract:The prolonged lag in T cell recovery seen in older patients undergoing hematopoietic stem cell transplant (HSCT), after chemo-/radiotherapy, can lead to immune dysfunction. As a result, recovering patients may experience a relapse in malignancies and opportunistic infections, leading to high mortality rates. The delay in T cell recovery is partly due to thymic involution, a natural collapse in the size and function of the thymus, as individuals age, and partly due to the damage sustained by the thymic stromal cells through exposure to chemo-/radiotherapy. There is a clear need for new strategies to accelerate intrathymic T cell reconstitution when treating aged patients to counter the effects of involution and cancer therapy regimens. Adoptive transfer of human progenitor T (proT) cells has been shown to accelerate T cell regeneration in radiation-treated young mice and to restore thymic architecture in immunodeficient mice. Here, we demonstrate that the adoptive transfer of in vitro -generated proT cells in aged mice (18-24 months) accelerated thymic reconstitution after treatment with chemotherapy and gamma irradiation compared to HSCT alone. We noted that aged mice appeared to have a more limited expansion of CD4-CD8- thymocytes and slower temporal kinetics in the development of donor proT cells into mature T cells, when compared to younger mice, despite following the same chemo/radiation regimen. This suggests a greater resilience of the young thymus compared to the aged thymus. Nevertheless, newly generated T cells from proT cell engrafted aged and young mice were readily present in the periphery accelerating the reappearance of new naïve T cells. Accelerated T cell recovery was also observed in both aged and young mice receiving both proT cells and HSCT. The strategy of transferring proT cells can potentially be used as an effective cellular therapy in aged patients to improve immune recovery and reduce the risk of opportunistic infections post-HSCT.

Recombinant FOXN1 fusion protein increases T cell generation in old mice

Recombinant FOXN1 fusion protein increases T cell generation in aged mice

FOXN1 Recombinant Protein Enhances T‐cell Regeneration after Hematopoietic Stem Cell Transplantation in Mice

Foxn1 overexpression promotes thymic epithelial progenitor cell proliferation and mTEC maintenance, but does not prevent thymic involution

Increased Hepatic Forkhead Box M1b (foxm1b) Levels in Old-Aged Mice Stimulated Liver Regeneration Through Diminished P27(Kip1) Protein Levels and Increased Cdc25b Expression

Thymus Reconstitution in Young and Aged Mice Is Facilitated by In Vitro-Generated Progenitor T Cells

FOXO1 constrains activation and regulates senescence in CD8 T cells

Role of the P63-Foxn1 Regulatory Axis in Thymic Epithelial Cell Homeostasis During Aging

RANKL treatment restores thymic function and improves T cell–mediated immune responses in aged mice

Mechanisms underlying the direct programming of mouse embryonic fibroblasts to thymic epithelial cells by FOXN1

Defining the impact of FOXN1 variants with functional assays and reaggregate thymus organ cultures reveals those with loss- and gain- of function and dominant negative consequences

T cell receptor excision circle assessment of thymopoiesis in aging mice

Type 1 interferons and Foxo1 down-regulation play a key role in age-related T-cell exhaustion in mice

Atrophied thymus creates tTreg repertoire holes altering an antigen-specific population in the periphery

FOXO1 deficiency impairs proteostasis in aged T cells

Thymic atrophy creates holes in Treg-mediated immuno-regulation via impairment of an antigen-specific clone

Thymus aging and immune reconstitution, progresses and challenges

Thymic microenvironment's impact on immunosenescence

Ageing promotes early T follicular helper cell differentiation by modulating expression of RBPJ

Excessive apoptosis of naïve T cells resulting hyperactivation as a cause of mammalian aging

FOXO1 differentially regulates bone formation in young and aged mice